Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity

Michael T. Lotze, William J. Buchser, Xiaoyan Liang

Research output: Contribution to journalShort survey

17 Scopus citations

Fingerprint Dive into the research topics of 'Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences